LAVI — Lavipharm SA Cashflow Statement
0.000.00%
Last trade - 00:00- €276.89m
- €303.45m
- €62.58m
Annual cashflow statement for Lavipharm SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.75 | 2.14 | 3.13 | 3.6 | 7.5 |
| Depreciation | |||||
| Non-Cash Items | 4.17 | 4.8 | 1.68 | 5.04 | 1.98 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.74 | -5.3 | -8.87 | -8.58 | -8.03 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3.82 | 3.35 | 0.284 | 4.64 | 6.67 |
| Capital Expenditures | -1.92 | -35.6 | -4.12 | -9.64 | -4.62 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.034 | 0.026 | 0.659 | 0.144 | 3.68 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.88 | -35.6 | -3.46 | -9.5 | -0.938 |
| Financing Cash Flow Items | — | — | -0.001 | -0.659 | 1.68 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2.23 | 48.8 | -6.63 | 2.16 | -5.35 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.294 | 16.6 | -9.81 | -2.7 | 0.379 |